Skip to main content

Advertisement

Log in

Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Apoptosis is a physiological process by which multicellular organisms eliminate superfluous cells. Alterations in apoptosis play a key role in tumour development. The objective was to evaluate the immunohistochemical expression of p53, p21, bax, bak, fas, bcl-2 and bcl-x proteins in 10 endometriomas, 20 benign ovarian tumours (10 mucinous, 10 serous) and 30 malignant ovarian tumours (9 mucinous, 19 serous; 2 endometrioids). p53 positive cells (mean±SD) in endometriomas, and benign and malignant tumours were 1.9±3.2, 0 and 16.2±33.0, respectively. The difference was significant between benign tumours and endometriomas (P=0.003) but not between endometriomas and malignant tumours. P21 expression in endometriomas and benign and malignant tumours was 19.5±27.8, 1.7±6.7 and 4.1±8.6, respectively. Increased p21 expression was found in endometriomas compared with benign (P=0.001) and malignant (P=0.01) tumours. Bax expression was higher in endometriomas than in benign tumours (P=0.01), but no difference was found between endometriomas and malignant tumours. No difference in bak, fas, bcl-2 or bcl-x expression was observed among the groups. In endometriomas, a negative correlation was found between p53 and fas expression (P=0.04, r=0.66). Although endometriomas have histological features of benign ovarian tumours, endometriomas share with malignant ovarian tumours certain alterations in apoptosis-related proteins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Athanassiadou P, Petrakakou E, Sakelariou V, Zerva C, Liossi A, Michalas S, Athanassiades P (1998) Expression of p53, bcl-2 and heat shock protein (hsp72) in malignant and benign ovarian tumours. Eur J Cancer Prev 7:225–231

    CAS  PubMed  Google Scholar 

  2. Attardi LD, Lowe SW, Brugarolas J, Jacks T (1996) Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis. EMBO J 15:3693–3701

    CAS  Google Scholar 

  3. Bayramoglu H, Duzcan E (2001) Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis. Pathol Oncol Res 7:33–38

    CAS  PubMed  Google Scholar 

  4. Ben-Hur H, Gurevich P, Huszar M, et al (1999) Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies. Eur J Gynaecol Oncol 20:249–253

    CAS  PubMed  Google Scholar 

  5. Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552–557

    Google Scholar 

  6. Chan WY, Cheung KK, Schorge JO, et al (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156:409–417

    CAS  PubMed  Google Scholar 

  7. Chang CC, Hsieh YY, Tsai FJ, Tsai CH, Tsai HD, Lin CC (2002) The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77:43–45

    Article  PubMed  Google Scholar 

  8. Darai E, Bringuier AF, Walker-Combrouze F, Feldmann G, Madelenat P, Scoazec JY (1998) Soluble adhesion molecules in serum and cysts fluids from patients with cystic tumours of the ovary. Hum Reprod 13:2831–2835

    Article  CAS  PubMed  Google Scholar 

  9. Darai E, Leblanc M, Walker-Combrouze F, Bringuier AF, Madelenat P, Scoazec JY (1998) Expression of cadherins and CD44 isoforms in ovarian endometrial cysts. Hum Reprod 13:1346–1352

    CAS  PubMed  Google Scholar 

  10. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675–684

    CAS  PubMed  Google Scholar 

  11. Gottlieb TM, Oren M (1998) p53 and apoptosis. Semin Cancer Biol 8:359–368

    Article  CAS  PubMed  Google Scholar 

  12. Goumenou A, Panayiotides I, Matalliotakis I, Vlachonikolis I, Tzardi M, and Koumantakis E (2001) Bcl-2 and Bax expression in human endometriotic and adenomyotic tissues. Eur J Obstet Gynecol Reprod Biol 99:256–260

    Article  CAS  PubMed  Google Scholar 

  13. Harada M, Suganuma N, Furuhashi M, Nagasaka T, Nakashima N, Kikkawa F, Tomoda Y, Furui K (1996) Detection of apoptosis in human endometriotic tissues. Mol Hum Reprod 2:307–315

    CAS  PubMed  Google Scholar 

  14. Heaps JM, Nieberg RK, Berek JS (1990) Malignant neoplasms arising in endometriosis. Obstet Gynecol 75:1023–1028

    CAS  PubMed  Google Scholar 

  15. Hsieh YY, Tsai FJ, Chang CC, Chen WC, Tsai CH, Tsai HD, Lin CC (2001) p21 gene codon 31 arginine/serine polymorphism: non-association with endometriosis. J Clin Lab Anal 15:184–187

    Article  CAS  PubMed  Google Scholar 

  16. Hsu SY, Hsueh AJ (2000) Tissue-specific Bcl-2 protein partners in apoptosis: an ovarian paradigm. Physiol Rev 80:593–614

    Google Scholar 

  17. International Federation of Gynecology and Obstetrics (1971) Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 50:1–7

    PubMed  Google Scholar 

  18. Jenkins S, Olive DL, Haney AF (1986) Endometriosis: pathogenetic implications of the anatomic distribution. Obstet Gynecol 67:335–338

    CAS  PubMed  Google Scholar 

  19. Jones RK, Searle RF, Bulmer JN (1998) Apoptosis and bcl-2 expression in normal human endometrium, endometriosis and adenomyosis. Hum Reprod 13:3496–3502

    Article  CAS  PubMed  Google Scholar 

  20. Kerr JF, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257

    PubMed  Google Scholar 

  21. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ (1995) Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270:96–99

    CAS  PubMed  Google Scholar 

  22. Kokawa K, Shikone T, Otani T, et al (2001) Apoptosis and the expression of bax and bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum Reprod 16:2211–2218

    Article  CAS  PubMed  Google Scholar 

  23. Lebovic DI, Mueller MD, Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75:1–10

    Article  CAS  PubMed  Google Scholar 

  24. Marone M, Scambia G, Mozzetti S, et al (1998) Bcl-2, bax, bcl-xl, and bcl-xs expression in normal and neoplastic ovarian tissues. Clin Cancer Res 4:517–524

    CAS  PubMed  Google Scholar 

  25. McCurrach ME, Connor TM, Knudson CM, Korsmeyer SJ, Lowe SW (1997) Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Natl Acad Sci U S A 94:2345–2349

    Article  CAS  PubMed  Google Scholar 

  26. McLaren J, Prentice A, Charnok-Jones DS, Sharkey AM, Smith SK (1997) Immunolocalization of the apoptosis regulating proteins bcl-2 and bax in human endometrium and isolated peritoneal fluid macrophages in endometriosis. Hum Reprod 12:146–152

    CAS  PubMed  Google Scholar 

  27. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS (2000) Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 74:760–766

    Article  CAS  PubMed  Google Scholar 

  28. Nagata S (1994) Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57:129–144

    PubMed  Google Scholar 

  29. Nakayama K, Toki T, Zhai YL, Lu X, Horiuchi A, Nikaido T, Konishi I, Fujii S (2001) Demonstration of focal p53 expression without genetic alterations in endometriotic lesions. Int J Gynecol Pathol 20:227–231

    CAS  PubMed  Google Scholar 

  30. Nezhat FR, Kalir T (2002) Comparative immunohistochemical studies of endometriosis lesions and endometriotic cysts. Fertil Steril 78:820–824

    Article  PubMed  Google Scholar 

  31. Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T (2002) Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94:2935–2940

    Article  CAS  PubMed  Google Scholar 

  32. Owen-Schaub LB, Zhang W, Cusack JC, et al (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032–3040

    CAS  PubMed  Google Scholar 

  33. Ridley JH (1968) The histogenesis of endometriosis. A review of facts and fancies. Obstet Gynecol 23:1–35

    Google Scholar 

  34. Ryan IP, Taylor RN (1997) Endometriosis and infertility: new concepts. Obstet Gynecol Surv 52:365–371

    Article  CAS  PubMed  Google Scholar 

  35. Sampson JA (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–469

    Google Scholar 

  36. Schneider J, Jimenez E, Rodriguez F, del Tanago JG (1998) c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep 5:49–52

    CAS  PubMed  Google Scholar 

  37. Stovall DW, Bowser LM, Archer DF, Guzick DS (1997) Endometriosis-associated pelvic pain: evidence for an association between the stage of disease and a history of chronic pelvic pain. Fertil Steril 68:13–18

    Article  CAS  PubMed  Google Scholar 

  38. Suganuma N, Harada M, Furuhashi M, Nawa A, Kikkawa F (1997) Apoptosis in human endometrial and endometriotic tissues. Horm Res 48:42–47

    CAS  PubMed  Google Scholar 

  39. Vaux Dl, Cory S, Adams JM (1988) Bcl-2 gene promotes haematopoetic cell survival and co-operates with c-myc to immortalize pre-B cells. Nature 335:440–442

    CAS  PubMed  Google Scholar 

  40. Vercellini P, Trespidi L, De Giorgi O (1996) Endometriosis and pelvic pain: relation to disease stage and localization. Fertil Steril 65:299–304

    CAS  PubMed  Google Scholar 

  41. Vogt J (1872) Untersuchungen uber die Entwicklungsgeschichte der Geburtshelferkroete (Alytes obstetricians). Jent & Gassman, Solothurn, Switzerland

  42. Watanabe H, Kanzaki H, Narukawa S, Inoue T, Katsuragawa H, Kaneko Y, and Mori T (1997) Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 176:360–368

    CAS  PubMed  Google Scholar 

  43. Werness BA, Freedman AN, Piver MS, Romero-Gutierrez M, Petrow E (1999) Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary. Gynecol Oncol 75:413–418

    Article  CAS  PubMed  Google Scholar 

  44. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T (1997) Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637–640

    CAS  PubMed  Google Scholar 

  45. Zusman I, Gurevich P, Gurevich E, Ben-Hur H (2001) The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review). Int J Oncol 18:965–972

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emile Daraï.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fauvet, R., Poncelet, C., Hugol, D. et al. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours. Virchows Arch 443, 38–43 (2003). https://doi.org/10.1007/s00428-003-0813-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-003-0813-3

Keywords

Navigation